Qarziba (Dinutusimabi Beta) Choice For Time 22.4.-31.12.2025 + Option 2026 For Northern Ostrobothnia'S Drug Ranks

  Address - Finland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 105929455

  Document Type - Tender Notices

Description - Description: Qarziba (Dinutusimabi beta preparation) Direct acquisition. There is only one distinction in the Finnish market Beta preparation Qarziba. Qarziba preparation is selected for the purpose of the SPC: for the treatment of high-risk neurobla stoma for patients at least 12 months. Finland is currently handling children with high-risk neuroblastoma with an international HR-NBL 1.8 Siopen treatment chart, part of which is Qarziba medication.local title:: Qarziba (dinutuksimabi beeta)-lääkevalmisteen valinta ajalle 22.4.-31.12.2025 + optio 2026 Pohjois-Pohjanmaan hyvintointialueen lääkehankintarenkaalleContract Type: : Supplylocal description: : Qarziba (dinutuksimabi beeta- valmiste

Gt Ref Id - 105929455

Deadline - Apr 11, 2025